Towards Healthcare

Cholera Vaccines Companies, Corporate Milestones, Corporate Growth and Development Strategy, Mergers and Acquisitions (M&A)

Date: January 2025

Cholera Vaccines Companies and Competitive Landscape

The global cholera vaccines market size is calculated at USD 94.5 million in 2024, grew to USD 103.99 million in 2025, and is projected to reach around USD 246 million by 2034. The market is expanding at a CAGR of 10.04% between 2024 and 2034.

Top Companies in the Cholera Vaccines

  • Bavarian Nordic A/S
  • Bharat Biotech
  • Biological E.
  • Celldex Therapeutics
  • EuBiologics
  • GlaxoSmithKline
  • Hilleman Laboratories
  • Pfizer
  • Sanofi S.A.
  • Shanghai United Cell Biotechnology Co. Ltd.
  • Shantha Biotechnics
  • Valneva Sweden AB

Recent Developments in the Cholera Vaccines Market

  • In August 2024, Bharat Biotech announced the launch of its new oral cholera vaccine, Hillchol, after achieving positive results from phase 3 trials. Hillchol was developed under the license from Singapore-based Hilleman Laboratories and will produce the vaccine with a capacity of 200 million doses.
  • In April 2024, the WHO approved the pre-qualification of a novel cholera vaccine, Euvichol-S, developed by EuBiologics in collaboration with the Bill and Melinda Gates Foundation. Euvichol-S is a simplified formulation of Euvichol-Plus, reducing the number of vaccine components.
CONSIGNEE NAME SHIPPER NAME PRODUCT DESCRIPTION QUANTITY WEIGHT
METROPOLITAN KITCHENS AND COUNTER TOP GOLDEN HOUSE DECORATION AND FURNITURE HOLLOW LUAN DOOR MEDICINE CABINET WHITE 1420 13500
CHR HANSEN INC CHR HANSEN A S NUTRITIONAL SUPPLEMENTS 12 4273
PBC NUTRITIONALS INC CHAUCER FOODS FREEZE DRIED SMOOTHIE ORGANICNET WEIGHT 17794 4228
PROFARM GROUP INC E NEMA GMBH STC PESTIZIDES 22 23804
ALL WOOD SUPPLY WHOLESALE INC FOSHAN FANCOME TRADE CO LIMITED WOOD MEDICINE CABINETS CERAMIC BASIN BRONZE STATUES 940 9530